Abacavir
An NRTI. **Requires HLA-B*5701 genetic testing** before use due to risk of life-threatening hypersensitivity reaction.
Dosage by Body Weight
Pediatric dose: 8 mg/kg twice daily or 16 mg/kg once daily. Do not start without negative HLA test.
- Body Weight
- 14-20 kg
- Dose
- 150 mg
- Frequency
- Twice daily
- Tracking Notes
- Can be taken with or without food.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| 14-20 kg | 150 mg | Twice daily | Can be taken with or without food. |
Formulation
Purpose
Part of combination therapy for HIV-1 infection.
Generic Name
Abacavir SulfateBranded Drug Names
Abacavir is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.
Alternatives
Safety Advice
Alcohol
CAUTIONAbacavir: Alcohol may worsen dizziness, nausea, dehydration, or liver strain during antiviral treatment. Avoid or limit alcohol.
Pregnancy
SAFE IF PRESCRIBEDAbacavir: Use during pregnancy only when prescribed; treatment may be important for maternal infection control or prevention of transmission.
Breast Feeding
SAFE IF PRESCRIBEDAbacavir: Breastfeeding advice depends on the infection and treatment regimen. Use only with healthcare provider guidance.
Driving
CAUTIONAbacavir: May cause dizziness, fatigue, sleep disturbance, or headache. Avoid driving if alertness is affected.
Liver
CAUTIONAbacavir: Some antivirals can affect liver function or require monitoring in hepatitis, HIV, or severe illness.
Kidney
CAUTIONAbacavir: Several antivirals are cleared by the kidneys and may need dose adjustment or hydration. Consult your healthcare provider.